Academic Journal

High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: A KONSAR Program in 2004

التفاصيل البيبلوغرافية
العنوان: High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: A KONSAR Program in 2004
المساهمون: Kyungwon Lee, Chang Hyun Lim, Ji Hyun Cho, Wee Gyo Lee, Young Uh, Hwi Jun Kim, Dongeun Yong, Yunsop Chong, Yong, Dong Eun, Lee, Kyung Won
المصدر: T200601078.pdf
سنة النشر: 2006
مصطلحات موضوعية: Acinetobacter/drug effects, Acinetobacter/isolation & purification, Anti-Bacterial Agents/pharmacology, Ceftazidime/pharmacology, Drug Resistance, Multiple, Bacterial, Gammaproteobacteria/drug effects, Gammaproteobacteria/isolation & purification, Hospitals, Imipenem/pharmacology, Klebsiella pneumoniae/drug effects, Klebsiella pneumoniae/isolation & purification, Korea, Laboratories, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Pseudomonas aeruginosa/isolation & purification, Antimicrobial resistance surveillance, ceftazidime resistance, imipenem resistance
الوصف: A nationwide antimicrobial resistance surveillance has been conducted since 1997 in Korea. In this study, susceptibility test data generated in 2004 by KONSAR group hospitals were analyzed and compared to those at a commercial laboratory. In hospitals, the rank orders of organisms in 2004 were identical to those in 2003. The most prevalent species was Staphylococcus aureus (20.2%) in hospitals, but Escherichia coli (29.7%) in the commercial laboratory. The proportions of Enterococcus faecium to all isolates of Enterococcus faecalis plus E. faecium were 47.2% in hospitals and 24.9% in the commercial laboratory. The mean resistance rates of significant antimicrobial-organism combinations in hospitals were: oxacillin-resistant S. aureus (68%), oxacillin-resistant (penicillin-nonsusceptible) Streptococcus pneumoniae (68%), vancomycin-resistant E. faecium (25%), cefotaxime-resistant E. coli (14%), ceftazidime- and cefoxitin-resistant Klebsiella pneumoniae (34% and 32%, respectively), and imipenem-resistant Acinetobacter spp. and Pseudomonas aeruginosa (17% and 24%, respectively). In conclusion, oxacillin-resistant staphylococci, expanded-spectrum cephalosporin-resistant K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa were prevalent in 2004. Increasing trends were observed for vancomycin-resistant E. faecium, cefoxitin-resistant E. coli and K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa. Certain antimicrobial-organism combinations were also prevalent among the commercial laboratory-tested strains. ; open
نوع الوثيقة: article in journal/newspaper
وصف الملف: 634~645
اللغة: unknown
تدمد: 0513-5796
1976-2437
Relation: YONSEI MEDICAL JOURNAL; J02813; OAK-2006-01303; https://ir.ymlib.yonsei.ac.kr/handle/22282913/110043; T200601078; YONSEI MEDICAL JOURNAL, Vol.47(5) : 634-645, 2006
DOI: 10.3349/ymj.2006.47.5.634
الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/110043
https://doi.org/10.3349/ymj.2006.47.5.634
Rights: CC BY-NC-ND 2.0 KR ; https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ ; free
رقم الانضمام: edsbas.38909026
قاعدة البيانات: BASE
الوصف
تدمد:05135796
19762437
DOI:10.3349/ymj.2006.47.5.634